The Charleston ended at midnight. David Goldstein felt the music stop in his chest like a heart giving out, and the room went quiet except for the clink of glasses and the low murmur of conversations that had nothing to do with him.

He was standing in the corner of a speakeasy on 135th Street, a glass of gin in his hand that he wasn't drinking, watching a woman in a silver dress dance with a man whose name David couldn't remember. The jazz band was packing up. Tomorrow he'd be back at Rockefeller Institute, running the same centrifuge experiments he'd been running for months. The same experiments that wouldn't change anything.

Except everything.

Three days ago, Dr. Harrow had called him into his office and closed the door. He'd slid a piece of paper across the desk — a genetic analysis report, typed and formal. David had read it once. He'd read it again. The words meant the same thing both times.

Carrier of the Goldstein lethal mutation. Expected onset: severe symptoms by age twenty-seven. Prognosis: fatal.

David was twenty-four.

He'd walked out of the office, back to the laboratory, and continued running the centrifuge as though nothing had changed. Because nothing had changed — not yet. The mutation was a clock ticking inside his cells, and clocks didn't care about your plans.

"Hey, Doc."

David turned. Eleanor O'Brien was standing beside him, holding two glasses of gin. She was Irish — dark-haired, sharp-eyed, with the kind of pragmatism that only came from growing up poor and refusing to stay there. She handed him a glass.

"You disappeared at midnight," she said. "I was starting to think you'd gone back to the lab."

"I almost did."

Eleanor studied his face. She had a talent for this — looking at him the way a physician looks at a patient, reading what he wasn't saying. But Eleanor wasn't just a physician. She was a colleague, a friend, and — David hadn't decided what else.

"Something wrong?" she asked.

David looked at his gin. He could tell her. He could hand her the report, let her read the words that were currently eating his cells alive. Or he could say nothing, go back to the speakeasy, dance the Charleston one more time, and pretend that being twenty-four felt like being eighty.

"No," he said. "Just tired."

Eleanor held his gaze for a moment longer. Then she nodded. She didn't press. But he saw — just for a second — the flicker in her eyes. The doctor recognizing another doctor's lie.

They walked out into the Harlem night. The street was wet from rain. Neon from a jazz club reflected on the pavement. Somewhere, a trumpet was playing.

"You know," Eleanor said, "there's something I need to show you."

"What is it?"

"A paper. From 1910. It's in the archives — German, originally. A researcher named Dr. Weber published something that the board decided wasn't worth pursuing. But I've been reading it, and David — it's beautiful. He was describing gene editing. Twenty years ahead of anyone."

"Gene editing," David repeated. The word was wrong — the right word wouldn't exist for another two decades. But the concept, the idea that you could reach into the body's blueprint and change a single letter, a single code...

"It's theoretical," Eleanor said. "Nobody knows how to do it. But the theory is sound. If someone could actually implement it..."

"If someone could implement it," David said slowly, "you could cure anything. Genetic diseases. Lethal mutations. Everything we've been losing to for generations."

Eleanor looked at him. "You think it's possible?"

David thought of the report in his desk drawer. He thought of the words Expected onset: fatal. He thought of three years — maybe less — before the mutation consumed him.

"I think," he said carefully, "it's the most important thing anyone has ever written."

They spent the next week in the Rockefeller archives, reading Weber's paper over and over, translating the German, checking the math. David barely slept. He barely ate. Every minute was dedicated to understanding what Weber had proposed and how it might be adapted to the scientific tools of 1924.

Eleanor stayed with him. She brought coffee and sandwiches and a patience that David found impossible to understand.

"Why are you helping me?" he asked on the third night, as they sat on the floor of the archive surrounded by photocopied pages. "This isn't my research."

"It is now," she said simply. "And if you're looking for a reason — someone has to do this work. Weber died alone in a German lab, unpublished and unappreciated. You're here. You're brilliant. And you have a reason to care that most researchers don't have."

David looked at her. He wanted to ask what she meant. He wanted to know if she knew about his diagnosis. He wanted to know if she knew and was still staying.

Instead, he picked up a page and continued reading.

Three weeks later, they had a working model. It was crude — far from practical, far from something that could be tested on a human being. But it was real. The theory was sound. The math worked. And David Goldstein, a Jewish-American geneticist with three years to live, had just invented something that would change the world.

He told no one.

Not because he was afraid — though he was, in a way. He was afraid of what the board would do if they knew. Professor Harrison would be thrilled. The academic community would be electrified. And the pharmaceutical companies — Pfizer, Merck, the whole established industry — would either buy the idea for pennies or bury it entirely.

No, he told no one because he wasn't ready. Not yet. He needed to be sure. He needed to run more tests. He needed to know that his father, his grandfather, every Goldstein who had died before their time, hadn't died for nothing.

But on a night in late March, Eleanor came to his apartment and found him asleep at his desk, surrounded by notes and calculations, a glass of cold tea on the edge of the page. She sat beside him and watched him sleep for a long time.

When he woke, the sun was rising through the window — a pale yellow light that made the pages on his desk glow.

"You need to eat," she said.

David stretched. His hands were stiff. His eyes were burning. But his mind was clear.

"I have something to show you," he said.

He showed her the model. He showed her the calculations. He showed her the path from theory to practice. Eleanor listened without interrupting, her expression shifting from curiosity to astonishment to something darker — fear, maybe, or recognition of the weight they were about to carry.

When he finished, she was silent for a long time.

"David," she said finally, "if you publish this, your career will be over before it starts."

"Why?"

"Because you'll be challenging every established authority in medicine. They won't be able to ignore this. And they won't want to."

David thought of his three years. He thought of the Goldstein family tree — line after line of men dying young, their names carved on headstones in a Brooklyn cemetery, their deaths attributed to "natural causes" when they were anything but.

"Then I'll publish it," he said. "And if they try to bury it, I'll make sure the whole world hears about it."

Eleanor looked at him with an expression he couldn't quite read. Respect, maybe. Or something that felt like fear.

"You're going to get yourself killed," she said quietly.

David smiled. It was the first time he'd smiled in weeks.

"I'm already dead," he said. "This is just the part where I decide how to die."

He didn't tell her about the diagnosis. He didn't need to. She would figure it out eventually — doctors always did. And when she did, she would understand why he was doing this.

Because David Goldstein had three years to live. And in those three years, he was going to plant a seed — a single idea, written in ink on paper — that would outlive him by a century.

The sower doesn't eat his own harvest. He plants it, and someone else reaps.

David Goldstein was a sower. And the harvest was coming.